Literature DB >> 12667502

Guide for the practical application of the ICRP Human Respiratory Tract Model. A report of ICRP supporting guidance 3: approved by ICRP committee 2 in October 2000.

J Valentin.   

Abstract

The ICRP Publication 66 Human Respiratory Tract Model for Radiological Protection (HRTM) has been applied to calculate dose coefficients (doses per unit intake) and bioassay functions in ICRP Publications 68, 71, 72 and 78. For these purposes, ICRP assigned numerical values to a range of model parameters, such as the size of the inhaled particles and the breathing rate of the subjects. These are known as 'default' or 'reference' values, and were chosen to be typical, representative values. In any particular situation the actual values of many parameters can be considerably different from the reference values. Usually, doses from intakes of radionuclides are low compared with the relevant limit or constraint, and the resulting difference is unimportant. There are, however, circumstances where more reliable assessments of intake and dose are desirable. This Guidance Document therefore gives advice on applying specific information within the framework of the HRTM for assessing occupational and environmental exposures and for interpreting bioassay data. Chapters on each aspect of the model (morphometry, physiology, deposition, clearance, gases and vapours, dosimetry) provide: A summary of how the HRTM treats that topic;Information on the reference values of relevant parameters;Guidance on choosing between default values;Information on how doses and bioassay quantities (lung retention, urine, and faecal excretion) vary with the values of selected parameters, giving guidance on the importance of obtaining specific information;Simple examples of the use of specific information relating to the topic.Annexes give additional information for those directly involved in applying the HRTM to specific situations, including guidance on obtaining parameter values. A brief overview is given of the deposition, characterisation, and sampling of aerosols, with references to further information, as there are relevant text books already available. Issues specific to radioactive aerosols, such as low particle number concentrations for high specific activity materials are, however, addressed. Guidance on obtaining information about absorption of inhaled radionuclides into blood is given in greater detail, because this is a topic on which ICRP has traditionally given guidance, and because a compilation of such information is not readily available elsewhere. Several detailed examples are also provided. One involves assessment of an individual's intake and committed dose from comprehensive bioassay monitoring data. The others deal with the derivation of HRTM absorption parameter values from experimental data, and their application, with additional information on e.g. size distribution, to calculate dose coefficients and interpret bioassay data.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12667502     DOI: 10.1016/S0146-6453(03)00011-3

Source DB:  PubMed          Journal:  Ann ICRP        ISSN: 0146-6453


  11 in total

1.  Behavior of submicrometer particles in periodic alveolar airflows.

Authors:  G Balik; A H Reis; M Aydin; A F Miguel
Journal:  Eur J Appl Physiol       Date:  2007-12-13       Impact factor: 3.078

2.  Absorbed fractions for electrons and beta particles in sensitive regions of human respiratory tract.

Authors:  V Markovic; N Stevanovic; D Nikezic
Journal:  Radiat Environ Biophys       Date:  2007-10-06       Impact factor: 1.925

3.  Interstitial IgG antibody pharmacokinetics assessed by combined in vivo- and physiologically-based pharmacokinetic modelling approaches.

Authors:  Miro J Eigenmann; Tine V Karlsen; Ben-Fillippo Krippendorff; Olav Tenstad; Ludivine Fronton; Michael B Otteneder; Helge Wiig
Journal:  J Physiol       Date:  2017-10-29       Impact factor: 5.182

Review 4.  Complex interactions between dietary and genetic factors impact lycopene metabolism and distribution.

Authors:  Nancy E Moran; John W Erdman; Steven K Clinton
Journal:  Arch Biochem Biophys       Date:  2013-07-08       Impact factor: 4.013

5.  Age-dependent inhalation doses to members of the public from indoor short-lived radon progeny.

Authors:  K Brudecki; W B Li; O Meisenberg; J Tschiersch; C Hoeschen; U Oeh
Journal:  Radiat Environ Biophys       Date:  2014-05-16       Impact factor: 1.925

6.  131I thyroid activity and committed dose assessment among family members of patients treated with radioactive iodine.

Authors:  K Brudecki; A Kluczewska-Gałka; P Zagrodzki; B Jarząb; K Gorzkiewicz; T Mróz
Journal:  Radiat Environ Biophys       Date:  2020-06-20       Impact factor: 1.925

Review 7.  Welding Fumes, a Risk Factor for Lung Diseases.

Authors:  Maria Grazia Riccelli; Matteo Goldoni; Diana Poli; Paola Mozzoni; Delia Cavallo; Massimo Corradi
Journal:  Int J Environ Res Public Health       Date:  2020-04-08       Impact factor: 3.390

8.  Estimation of Inhaled Effective Doses of Uranium and Thorium for Workers in Bayan Obo Ore and the Surrounding Public, Inner Mongolia, China.

Authors:  Yao Zhang; Xianzhang Shao; Liangliang Yin; Yanqin Ji
Journal:  Int J Environ Res Public Health       Date:  2021-01-22       Impact factor: 3.390

9.  Reduction of a Whole-Body Physiologically Based Pharmacokinetic Model to Stabilise the Bayesian Analysis of Clinical Data.

Authors:  Thierry Wendling; Nikolaos Tsamandouras; Swati Dumitras; Etienne Pigeolet; Kayode Ogungbenro; Leon Aarons
Journal:  AAPS J       Date:  2015-11-04       Impact factor: 4.009

10.  Application of a Bayesian approach to physiological modelling of mavoglurant population pharmacokinetics.

Authors:  Thierry Wendling; Swati Dumitras; Kayode Ogungbenro; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-08-01       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.